International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals Ltd has achieved a significant milestone with the United States Food & Drug Administration's approval for their generic version of Sumatriptan injection, used in combating ...

A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...

Aug 5 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India.

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections PIVYA expected to be available in the U.S. in the 4th ...

More Than 732,000 Bottles of a Blood Pressure Medication Were Just Recalled Nationwide More Than 9,000 Bottles of a Pain Reliever Have Been Recalled Nationwide More Than 230,000 Bottles of a Popular ...

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor Tablets for heart attack and stroke prevention, with 90 mg tablets matching AstraZeneca's Brilinta. Estimated market size ...